We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SW:NYSESmurfit WestRock plc Analysis

Data as of 2026-05-28 - not real-time

$39.88

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Smurfit Westrock’s stock is trading below its short‑term moving averages, signaling a bearish technical backdrop, while the MACD shows a modest bullish crossover and the RSI hovers near the midpoint, indicating limited momentum. Fundamentally, the company carries a very high price‑to‑earnings multiple, a dividend payout that exceeds earnings by a wide margin, and a debt load that dwarfs its cash position, all of which point to an overvalued valuation profile. The recent capacity reductions and industry‑wide price hikes are intended to improve margins, and analysts have lifted price targets, suggesting upside potential if the operational turnaround materialises.
However, earnings missed expectations, volume is on a downtrend, and the dividend sustainability is questionable given the excessive payout ratio. Investors should weigh the short‑term price pressure against the medium‑term upside implied by higher pricing power and analyst targets, while remaining mindful of the high leverage and earnings volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Recent earnings miss and decreasing volume
  • Price trading below key moving averages
  • MACD showing only a modest bullish signal

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst price targets indicating significant upside
  • Capacity cuts and price hikes improving margin outlook
  • Forward earnings multiple moving into a more reasonable range

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Structural demand for packaging supporting a baseline growth story
  • High leverage and low return metrics limiting upside
  • Dividend policy that may force future cuts

Key Metrics & Analysis

Financial Health

Revenue Growth0.70%
Profit Margin1.22%
P/E Ratio55.4
ROE2.11%
ROA3.01%
Debt/Equity78.83
P/B Ratio1.1
Op. Cash Flow$3.4B
Free Cash Flow$1.4B

Technical Analysis

TrendBearish
RSI52.0
Support$35.53
Resistance$42.71
MA 20$39.22
MA 50$39.85
MA 200$41.19
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value$9.24
Target Price$53.46
Upside/Downside34.06%
GradeOvervalued
TypeValue
Dividend Yield4.62%

Risk Assessment

Beta1.40
Volatility45.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.